Jefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm ...

However, due to the size of the class and final amounts still not approved, we do not expect swift settlement payments." To apply for a cash advance lawsuit loan from your anticipated GSK Zantac ...

Zantac settlement... GSK announced that it has reached a settlement agreement to resolve 93% of cases The settlement is expected to be $2.2 billion and will be implemented by mid 2025. GSK will ...

The FTSE 100 index slumped 99.42 points, 1.2%, at 8,025.77. The FTSE 250 closed down 295.73 points, 1.4%, at 20,427.80. The AIM All-Share fell 7.07 points, 1.0%, at 730.86.

To apply for a cash advance lawsuit loan from your anticipated GSK Zantac lawsuit settlement, please visit the company's website HERE or call 877.571.0405. Settlement monies are not expected ...

GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused ... estimating that liability and settlements could end up costing them billions ...

The Delaware hearings are viewed as the greatest near-term chance that the class actions against ranitidine manufacturers will be revived, and whether GSK may consider additional settlements.

The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...